MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX) announced today that the ThinPrep® Genesis processor for cytology slide and molecular test preparation has received a CE IVD mark in ...
Women in the Greater Auckland area will be able to get a ThinPrep cervical smear test from their doctor at no extra charge from today. Previously, there was an additional charge from the doctor for ...
We compared the sensitivity and specificity of liquid-based cytology (LBC) and computer-assisted reading for SurePath/FocalPoint and ThinPrep with those of manually read conventional cytology in ...
FRANKLIN LAKES, N.J., Sept. 23, 2020 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has submitted a pre-market ...
Chipping away at the dominance of the Pap smear -- a test that reigned unrivaled for nearly 50 years and spared thousands of women the ravages of cervical cancer -- has been a slow and arduous process ...
Women have been going to their gynecologists for Pap tests for more than 50 years. And their vigilance has paid off: Mortality rates from cervical cancer have dropped 70%, according to the American ...
Hologic, Inc. HOLX recently announced the receipt of FDA premarket approval (PMA) of ThinPrep Genesis processor for cytology processing and specimen transfer for downstream applications. Notably, the ...
Hologic, Inc. (Nasdaq: HOLX) announced today that the ThinPrep® Genesis processor for cytology slide and molecular test preparation has received a CE IVD mark in Europe. The system features increased ...
New instrument offers workflow, automation, chain of custody and ergonomic benefits to clinical labs Hologic, Inc. (Nasdaq: HOLX) announced today that the ThinPrep Genesis processor for cytology slide ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback